No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 2.4x · 10Y median 2.1x · 62nd percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T21:47:53.206Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T21:47:53.206Z. Latest historical point 2021-12-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T21:47:53.206Z. Latest historical point 2023-03-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T21:47:53.206Z. Latest historical point 2023-03-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T21:47:53.206Z. Latest historical point 2021-12-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T21:47:53.206Z. Latest historical point 2023-03-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T21:47:53.206Z. Latest historical point 2023-03-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Prenetics Global Limited (PRE) stock was $20.40 as of Oct 6, 2026, 4:00 PM EDT, down 2.67% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +46.6% · 3-year avg +47.0%/yr · 5-year avg -28.8%/yr
Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements.
Household & Personal Products · Hong Kong
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 9, 2026
34 days away
EPS Estimate
-0.82
Revenue Est.
$63.25M
Last Quarter Results
EPS
$-0.52
vs Estimate
$-0.48
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1PRE | $346.81M | $20.40 | -2.67% | +46.61% | -28.80% | N/A | N/A |
| 2AGCC | $341.80M | $15.00 | +0.00% | N/A | N/A | N/A | vs PRE |
| 3VFF | $339.85M | $2.79 | +2.57% | -4.21% | -19.61% | +9.83% | vs PRE |
| 4SNDL | $320.17M | $1.23 | -1.60% | -51.38% | -27.89% | N/A | vs PRE |
| 5AFRI | $313.86M | $11.64 | +3.28% | +29.53% | +2.34% | N/A | vs PRE |
| 6LWAY | $312.67M | $20.46 | -2.57% | -17.41% | +30.78% | +3.30% | vs PRE |
forward FY estimate
N/A
$46.49M
vs Estimate
$49.85M
Consensus Rating
Based on 7 analysts
Average Price Target
$35.86
+75.8% upside
Low
$30.00
Current
$20.40
High
$40.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-1.71 | $-0.82 | $-0.28 | 3 |
| Quarter ending Dec 2026 | $-1.90 | $-0.75 | $0.24 | 3 |
| Quarter ending Mar 2027 | $-0.53 | $-0.51 | $-0.48 | 1 |
| Quarter ending Jun 2027 | $-0.41 | $-0.39 | $-0.37 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-4.19 | $-3.53 | $-2.57 | 3 |
| FY 2027 | $-6.86 | $-1.79 | $2.32 | 4 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $62.81M | $63.25M | $63.60M | 5 |
| Quarter ending Dec 2026 | $75.33M | $77.92M | $80.45M | 5 |
| Quarter ending Mar 2027 | $81.85M | $85.01M | $87.63M | 4 |
| Quarter ending Jun 2027 | $91.92M | $95.48M | $98.41M | 4 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $220.60M | $223.61M | $226.16M | 6 |
| FY 2027 | $396.28M | $407.03M | $413.47M | 4 |
